1494 related articles for article (PubMed ID: 11276379)
41. Intraductal papillary mucinous neoplasm of the pancreas: associated cancers, family history, genetic predisposition?
Lubezky N; Ben-Haim M; Lahat G; Marmor S; Solar I; Brazowski E; Nackache R; Klausner JM
Surgery; 2012 Jan; 151(1):70-5. PubMed ID: 21975290
[TBL] [Abstract][Full Text] [Related]
42. Pancreatic Adenocarcinoma: Improving Prevention and Survivorship.
Sohal DPS; Willingham FF; Falconi M; Raphael KL; Crippa S
Am Soc Clin Oncol Educ Book; 2017; 37():301-310. PubMed ID: 28561672
[TBL] [Abstract][Full Text] [Related]
43. [Familial malignant melanoma].
Ueda M
Nihon Rinsho; 2000 Jul; 58(7):1381-4. PubMed ID: 10921309
[TBL] [Abstract][Full Text] [Related]
44. Hereditary factors in pancreatic cancer.
Lynch HT; Brand RE; Lynch JF; Fusaro RM; Kern SE
J Hepatobiliary Pancreat Surg; 2002; 9(1):12-31. PubMed ID: 12021894
[TBL] [Abstract][Full Text] [Related]
45. Familial and second primary pancreatic cancers: a nationwide epidemiologic study from Sweden.
Hemminki K; Li X
Int J Cancer; 2003 Feb; 103(4):525-30. PubMed ID: 12478670
[TBL] [Abstract][Full Text] [Related]
46. Implications and issues related to familial pancreatic cancer: a cohort study of hospitalized patients.
Mughetti M; Calculli L; Chiesa AM; Ciccarese F; Rrusho O; Pezzilli R
BMC Gastroenterol; 2016 Jan; 16():6. PubMed ID: 26767414
[TBL] [Abstract][Full Text] [Related]
47. Familial pancreatic cancer: challenging diagnostic approach and therapeutic management.
Mastoraki A; Chatzimavridou-Grigoriadou V; Chatzipetrou V; Mastoraki S; Papanikolaou IS; Danias N; Smyrniotis V; Arkadopoulos N
J Gastrointest Cancer; 2014 Sep; 45(3):256-61. PubMed ID: 24756831
[TBL] [Abstract][Full Text] [Related]
48. Double germline mutations in APC and BRCA2 in an individual with a pancreatic tumor.
Goehringer C; Sutter C; Kloor M; Gebert J; Slater EP; Keller M; Treiber I; Ganschow P; Kadmon M; Moog U
Fam Cancer; 2017 Apr; 16(2):303-309. PubMed ID: 27838800
[TBL] [Abstract][Full Text] [Related]
49. Deleterious Germline Mutations in Patients With Apparently Sporadic Pancreatic Adenocarcinoma.
Shindo K; Yu J; Suenaga M; Fesharakizadeh S; Cho C; Macgregor-Das A; Siddiqui A; Witmer PD; Tamura K; Song TJ; Navarro Almario JA; Brant A; Borges M; Ford M; Barkley T; He J; Weiss MJ; Wolfgang CL; Roberts NJ; Hruban RH; Klein AP; Goggins M
J Clin Oncol; 2017 Oct; 35(30):3382-3390. PubMed ID: 28767289
[TBL] [Abstract][Full Text] [Related]
50. Genetic predisposition to pancreatic cancer.
Ghiorzo P
World J Gastroenterol; 2014 Aug; 20(31):10778-89. PubMed ID: 25152581
[TBL] [Abstract][Full Text] [Related]
51. [Hereditary gastrointestinal neoplasias].
Fendrich V; Bartsch DK
Z Gastroenterol; 2005 Feb; 43(2):219-25. PubMed ID: 15700217
[TBL] [Abstract][Full Text] [Related]
52. Malignant cutaneous melanoma associated with neurofibromatosis in two sisters from a family with familial atypical multiple mole melanoma syndrome. Case reports and review of the literature.
Stokkel MP; Kroon BB; van der Sande JJ; Neering H
Cancer; 1993 Oct; 72(8):2370-5. PubMed ID: 8402451
[TBL] [Abstract][Full Text] [Related]
53. Genetic predisposition and environmental risk factors to pancreatic cancer: A review of the literature.
Landi S
Mutat Res; 2009; 681(2-3):299-307. PubMed ID: 19150414
[TBL] [Abstract][Full Text] [Related]
54. Pancreatic ductal adenocarcinoma: risk factors, screening, and early detection.
Becker AE; Hernandez YG; Frucht H; Lucas AL
World J Gastroenterol; 2014 Aug; 20(32):11182-98. PubMed ID: 25170203
[TBL] [Abstract][Full Text] [Related]
55. Hereditary melanoma: Update on syndromes and management: Genetics of familial atypical multiple mole melanoma syndrome.
Soura E; Eliades PJ; Shannon K; Stratigos AJ; Tsao H
J Am Acad Dermatol; 2016 Mar; 74(3):395-407; quiz 408-10. PubMed ID: 26892650
[TBL] [Abstract][Full Text] [Related]
56. Patients with both pancreatic adenocarcinoma and melanoma may harbor germline CDKN2A mutations.
Lal G; Liu L; Hogg D; Lassam NJ; Redston MS; Gallinger S
Genes Chromosomes Cancer; 2000 Apr; 27(4):358-61. PubMed ID: 10719365
[TBL] [Abstract][Full Text] [Related]
57. Linkage analysis in Dutch familial atypical multiple mole-melanoma (FAMMM) syndrome families. Effect of naevus count.
Gruis NA; Sandkuijl LA; Weber JL; van der Zee A; Borgstein AM; Bergman W; Frants RR
Melanoma Res; 1993 Aug; 3(4):271-7. PubMed ID: 8219760
[TBL] [Abstract][Full Text] [Related]
58. Atypical mole syndrome: risk factor for cutaneous malignant melanoma and implications for management.
Slade J; Marghoob AA; Salopek TG; Rigel DS; Kopf AW; Bart RS
J Am Acad Dermatol; 1995 Mar; 32(3):479-94. PubMed ID: 7868720
[TBL] [Abstract][Full Text] [Related]
59. Ectopic expression of tyrosinase increases melanin synthesis and cell death following UVB irradiation in fibroblasts from familial atypical multiple mole and melanoma (FAMMM) patients.
Yoneta A; Yamashita T; Jin HY; Kondo S; Jimbow K
Melanoma Res; 2004 Oct; 14(5):387-94. PubMed ID: 15457095
[TBL] [Abstract][Full Text] [Related]
60. Inherited susceptibility to several cancers but absence of linkage between dysplastic nevus syndrome and CDKN2A in a melanoma family with a mutation in the CDKN2A (P16INK4A) gene.
Puig S; Ruiz A; Castel T; Volpini V; Malvehy J; Cardellach F; Lynch M; Mascaro JM; Estivill X
Hum Genet; 1997 Dec; 101(3):359-64. PubMed ID: 9439668
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
